Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Convertible Debt: 2014

  • KalVista Pharmaceuticals' Convertible Debt was N/A to $2.1 million in Q4 2014 from the same period last year, while for Dec 2014 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2014, which is N/A change from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Convertible Debt of $2.1 million as of Q4 2014.
  • KalVista Pharmaceuticals' 5-year Convertible Debt high stood at $2.1 million for Q4 2014, and its period low was $2.1 million during Q4 2014.
  • Moreover, its 1-year median value for Convertible Debt was $2.1 million (2014), whereas its average is $2.1 million.